Medinotec Inc.
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
About Medinotec
Surgical & Medical Instruments & Apparatus, SIC 3841
Medinotec, Inc. is a medical device company that develops, manufactures, and distributes specialized interventional healthcare products. The company operates across two principal areas: proprietary medical devices and the distribution of third-party medical products under exclusive or non-exclusive agreements. Its proprietary offerings focus on interventional cardiology and interventional endolaryngeal endoscopy, featuring products such as the Trachealator non-occlusive airway dilation balloon, the Outflo aortic valve dilation balloon catheter, and the Cape Cross line of percutaneous transluminal coronary angioplasty balloon catheters. It also distributes cardiology and renal dialysis technologies. The company's customer base consists primarily of hospitals, healthcare providers, and specialized medical centers of excellence.
The company operates a manufacturing, warehousing, laboratory, and regulatory facility located in Johannesburg, South Africa. It maintains distribution arrangements and commercial channels across South Africa, Namibia, Mauritius, Europe, South America, portions of Asia, the Middle East, and the United States. Medinotec, Inc. maintains its principal executive offices in North Riding, Johannesburg, South Africa.
Summary of the business section of Medinotec's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Medinotec Inc.
- Founded
- 2021
- Headquarters
- Johannesburg, South Africa
- Address
- Northlands Deco Park, 10 New Market St., Stand 299 Avant Garde Avenue 2169
- Phone
- 27 87 330 2301
- Employees
- 48, Feb 28, 2026
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- February 28
- Auditor
- Mercurius & Associates LLP, New Delhi, India
Stock & identifiers
- Ticker
- MDNC
- Exchange
- OTC
- Shares outstanding
- 12M, Jul 15, 2026
- Public float
- $9.16M, Aug 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1931055
- CUSIP
- 58500G107
- ISIN
- US58500G1076
- EIN
- 36-4990343
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Gregory Vizirgianakis | President, Secretary, CEO, Director | 4,750,179 |
| Niekerk Pieter Mohr van | CFO, Director | 401,965 |
| Athanasios Spirakis | Director | 12,073 |
| Stavros G. Vizirgianakis | Director | 4,750,179 |
| Joseph P. Dwyer | Director | 0 |
Employees
Headcount reported in annual reports
“had 48 employees and independent contractors supporting its operations.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 16, 2025 | Late filing | Notification of late filing |
| Jul 10, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| May 29, 2024 | Late filing | Notification of late filing |
| Jan 12, 2024 | Late filing | Notification of late filing |
| Jun 21, 2023 | Auditor change | Change in certifying accountant (8-K Item 4.01) |